Revise HIPAA: Health researchers

A rule meant to protect the privacy of medical patients impedes critical health research by limiting access to stored tissue and genetic datasets and by hampering research participant recruitment, according to an Association of Academic Health Centers (AAHC) linkurl:report;http://www.aahcdc.org/policy/reddot/AAHC_HIPAA_Creating_Barriers.pdf released yesterday (Jun 16). This sentiment echoes linkurl:concerns;http://www.the-scientist.com/blog/display/53866/ previously voiced by US epidemiologists,

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A rule meant to protect the privacy of medical patients impedes critical health research by limiting access to stored tissue and genetic datasets and by hampering research participant recruitment, according to an Association of Academic Health Centers (AAHC) linkurl:report;http://www.aahcdc.org/policy/reddot/AAHC_HIPAA_Creating_Barriers.pdf released yesterday (Jun 16). This sentiment echoes linkurl:concerns;http://www.the-scientist.com/blog/display/53866/ previously voiced by US epidemiologists, who linkurl:said;http://jama.ama-assn.org/cgi/reprint/298/18/2164.pdf the Privacy Rule of the Health Insurance Portability and Accountability Act (HIPAA) has made their research more difficult to conduct since its enactment in 2003. The AAHC convened focus groups at several US academic medical centers, and researchers and administrators there said that HIPAA increased administrative burden with additional paperwork, created confusion over the rule's ambiguous wording, and made it harder for investigators to identify eligible study participants by reviewing their medical records. The red tape created by the rule was particularly detrimental to studies involving stored tissues and linkurl:genetic datasets.;http://www.the-scientist.com/news/display/53554/ Because HIPAA makes it more difficult to track patients after a study is completed, investigators may be unable to find and inform study participants of treatments for genetic linkurl:mutations;http://www.the-scientist.com/news/display/38329/ that made them eligible for past studies. Additionally, community health providers and other community researchers might be shying away from participating in broad-scale clinical studies because of potential liability issues raised by HIPAA, the report states. The AAHC recommends that the US Department of Health and Human Services revise HIPAA in a way that continues to protect the privacy of clinical research participants while making studies easier to conduct. The organization also calls on Congress to enact a national genetic privacy act that will not limit access to genetic datasets or tissue banks in the way that HIPAA now does.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences